News9 months ago
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Update
Genelux Corporation WESTLAKE VILLAGE, Calif., May 9, 2024 (GLOBE NEWSWIRE) – Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced Q1 2024 financial results...